[Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
Costa
F V
FV
Borghi
C
C
Mussi
A
A
Ambrosioni
E
E
D000328:Adult; D002191:Canrenoic Acid / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000378:metabolism*; D011245:Pregnadienes / Q000627:therapeutic use*; D011897:Random Allocation; D012964:Sodium / Q000378:metabolism*
D011245:Pregnadienes; D006852:Hydrochlorothiazide; D002191:Canrenoic Acid; D012964:Sodium; D011188:Potassium; C009732:buthiazide
Efficacia antipertensiva ed effetti sugli elettroliti intra- ed extracellulari della associazione canrenoato di potassio-butizide.